Cancerous disease modifying antibodies
Details for Australian Patent Application No. 2007278792 (hide)
International Classifications
Event Publications
19 February 2009 Assignment before Grant
Arius Research Inc. The application has been assigned to F. Hoffmann-La Roche AG Assignments before Grant, Section 113
19 February 2009 PCT application entered the National Phase
PCT publication WO2008/011711 Priority application(s): WO2008/011711
24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007278798-Apparatus for access control, and read/ write device
2007278791-Cytotoxicity mediation of cells evidencing surface expression of CD63
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser